What is the effect of the left oxygen anti-inflammatory injection

Diseases are very common in people's daily lives. Many factors in life can contribute to the occurrence of diseases. Drug treatment is the most common way to treat diseases. Levodopa anti-inflammatory injection is a therapeutic drug for inflammatory diseases, but most people are not clear about the specific efficacy and effects of this drug. So, what is the effect of the left oxygen anti-inflammatory injection?

First, what is the effect of the left oxygen anti-inflammatory injection? This drug is a type of quinolone drug with a broad-spectrum antibacterial effect and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella and Gram-negative bacteria such as Haemophilus influenzae, Legionella pneumophila, and Neisseria gonorrhoeae. It also has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Mycoplasma pneumoniae, and Chlamydia pneumoniae, but its effect on anaerobic bacteria and enterococci is poor.

Second, the drug has achieved good results in treating respiratory tract infections, urinary and reproductive system infections, and skin and soft tissue infections. The efficacy and bacterial clearance rate of the drug in treating acute and chronic lower respiratory tract infections are as high as 80% to 100%. The clearance rate for Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus and Pneumococcus is high, while the clearance rate for Pseudomonas aeruginosa is poor. The efficacy and bacterial clearance rate for complicated and simple urinary tract infections are also 80% to 100%. The efficacy of treating skin and soft tissue infections is 80% to 91%, and the elimination rate of methicillin-sensitive Staphylococcus aureus is close to 90%. The effectiveness of treating gynecological, ear, nose, throat and other infections is also around 90%. The following infections caused by bacteria that are sensitive to this drug, including Staphylococcus, Pneumococcus, Streptococcus pyogenes, Streptococcus pyogenes, Enterococcus, Peptostreptococcus, Neisseria gonorrhoeae, Catarrhalis brahamella, Propionibacterium acnes, Escherichia coli, Citrobacter, Salmonella (excluding Salmonella typhi and Paratyphi), Shigella, Klebsiella, Enterobacter, Serratia, Proteus, Vibrio cholerae, Pseudomonas aeruginosa, Haemophilus influenzae, Acinetobacter, Campylobacter, and Chlamydia trachomatis. - Pneumonia, chronic bronchitis, diffuse bronchiolitis, bronchiectasis (infection), secondary infection of chronic respiratory diseases. - Pharyngitis, tonsillitis (peritonsillitis, peritonsillar abscess), acute bronchitis - Pyelonephritis, cystitis, prostatitis, epididymitis, gonococcal urethritis, non-gonococcal urethritis. - Intrauterine infection, cervicitis, adnexitis, vestibular gland inflammation. - Folliculitis (including pustular acne), furuncle, furunculosis, carbuncle contagious impetigo, erysipelas, cellulitis, lymphangitis (adenitis), suppurative perionychia (including whitlow), subcutaneous abscess, sweat gland inflammation, clustered acne, infectious atheroma, perianal abscess. - Secondary infection of mastitis, trauma, scald and surgical wounds (superficial).

What is the effect of levofloxacin anti-inflammatory injection? For elderly people, the dosage of levofloxacin should be reduced to 100 mg, once every 12 hours. Some clinicians lack understanding of this regulation, resulting in little difference in dosage between the elderly and adults. It should be noted that injection of 200-300 mg of levofloxacin is relatively safe for adults, but it is often difficult for the elderly, especially elderly patients, to tolerate and may even cause adverse consequences. The kidneys, heart, liver and nervous system of the elderly are declining, and the body's water content is reduced, so it is easy to form high blood drug concentration levels and difficult to excrete. Therefore, the dose of levofloxacin should be selected according to the specific circumstances of the elderly individual. Pay attention to selecting the dosage of levofloxacin injection according to individual differences in women. Among patients using levofloxacin injection, adverse reactions such as nausea, vomiting, headache, dizziness, palpitations and insomnia are more common in women. Among them, women who are thin, obviously underweight, and those who are trying to lose weight are the most susceptible groups. This is not accidental, but because the commonly used doses will cause the blood drug concentration levels of the above individuals to be higher than that of normal people, and their heart, nervous system and gastrointestinal tract have relatively poor tolerance. The injection dose of levofloxacin should be different for men and women. For female patients who are thin and underweight, a single dose of levofloxacin should not exceed 200 mg.